AlphaCrest Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,642
| Closed | -$1.63M | – | 1249 |
|
|
2022
Q3 | $1.63M | Sell |
6,642
-649
| -9% | -$159K | 0.1% | 310 |
|
|
2022
Q2 | $1.81M | Buy |
7,291
+4,693
| +181% | +$1.16M | 0.09% | 376 |
|
|
2022
Q1 | $861K | Sell |
2,598
-8,120
| -76% | -$2.69M | 0.05% | 627 |
|
|
2021
Q4 | $3.85M | Buy |
10,718
+7,282
| +212% | +$2.62M | 0.14% | 147 |
|
|
2021
Q3 | $1.12M | Sell |
3,436
-829
| -19% | -$270K | 0.06% | 564 |
|
|
2021
Q2 | $1.33M | Sell |
4,265
-1,201
| -22% | -$375K | 0.06% | 528 |
|
|
2021
Q1 | $1.74M | Buy |
5,466
+4,189
| +328% | +$1.34M | 0.1% | 305 |
|
|
2020
Q4 | $414K | Sell |
1,277
-518
| -29% | -$168K | 0.03% | 762 |
|
|
2020
Q3 | $497K | Sell |
1,795
-252
| -12% | -$69.8K | 0.05% | 593 |
|
|
2020
Q2 | $494K | Sell |
2,047
-2,630
| -56% | -$635K | 0.08% | 394 |
|
|
2020
Q1 | $679K | Sell |
4,677
-3,052
| -39% | -$443K | 0.08% | 436 |
|
|
2019
Q4 | $1.32M | Sell |
7,729
-246
| -3% | -$42K | 0.11% | 235 |
|
|
2019
Q3 | $1.42M | Buy |
7,975
+4,019
| +102% | +$715K | 0.09% | 379 |
|
|
2019
Q2 | $1.03M | Sell |
3,956
-1,519
| -28% | -$395K | 0.09% | 385 |
|
|
2019
Q1 | $1.56M | Buy |
+5,475
| New | +$1.56M | 0.24% | 88 |
|